Averion International Corp. Appoints Glenn E. Deegan Vice President and General Counsel

BOSTON--(BUSINESS WIRE)--Averion International Corp. (OTCBB:AVRO), a clinical research organization (CRO) specializing in oncology, medical devices, dermatology and nephrology, today announced the appointment of Glenn E. Deegan as vice president and general counsel. Mr. Deegan’s responsibilities will include directing all Company legal matters including compliance with securities regulations, acquisitions and partnering activities, and corporate governance matters.
MORE ON THIS TOPIC